Randomized, double-blind comparison of 1 mg/L versus 5 mg/L methoxsalen bath-PUVA therapy for chronic plaque-type psoriasis

Journal of the American Academy of Dermatology

Volumn 55, Issue 4, 2006, Pages 627-631

  Vongthongsri, Rujirat ^a   Konschitzky, Reinhard ^a   Seeber, Arno ^b   Treitl, Christina ^a   Hönigsmann, Herbert ^a   Tanew, Adrian ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b Donauspital/SMZ Ost ^*

Author keywords

[No Author keywords available]

Indexed keywords

METHOXSALEN;

ADULT; ARTICLE; BALNEOTHERAPY; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DILUTION; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG TOLERABILITY; ERYTHEMA; FEMALE; HUMAN; INTERMETHOD COMPARISON; MALE; PHOTODERMATOSIS; PHOTOTOXICITY; PRIORITY JOURNAL; PRURITUS; PSORIASIS; PUVA; RADIATION DOSE; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; TREATMENT DURATION; ULTRAVIOLET A RADIATION;

ADULT; CHRONIC DISEASE; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; METHOXSALEN; MIDDLE AGED; PSORIASIS; PUVA THERAPY;

EID: 33749150157     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaad.2006.05.024     Document Type: Article

References (20)

1. Lüftl M., Degitz K., Plewig G., and Röcken M. Psoralen bath plus UV-A therapy. Possibilities and limitations. Arch Dermatol 133 (1997) 1597-1603
2. Lindelöf B., Sigurgeirsson B., Tegner E., Larkö O., and Berne B. Comparison of the carcinogenic potential of trioxsalen bath PUVA and oral methoxsalen PUVA. Arch Dermatol 128 (1992) 1341-1344
3. Hannuksela-Svahn A., Sigurgeirsson B., Pukkala E., Lindelöf B., Berne B., Hannuksela M., et al. Trioxsalen bath PUVA did not increase the risk of squamous cell skin carcinoma and cutaneous malignant melanoma in a joint analysis of 944 Swedish and Finnish patients with psoriasis. Br J Dermatol 141 (1999) 497-501
4. Lowe N.J., Weingarten D., Bourget T., and Moy L.S. PUVA therapy for psoriasis: comparison of oral and bath-water delivery of 8-methoxypsoralen. J Am Acad Dermatol 14 (1986) 754-760
5. Collins P., and Rogers S. Bath-water compared with oral delivery of 8-methoxypsoralen PUVA therapy for chronic plaque psoriasis. Br J Dermatol 127 (1992) 392-395
6. Calzavara-Pinton P.G., Ortel B., Hönigsmann H., Zane C., and De Panfilis G. Safety and effectiveness of an aggressive and individualized bath-PUVA regimen in the treatment of psoriasis. Dermatology 189 (1994) 256-259
7. Cooper E.J., Herd R.M., Priestley G.C., and Hunter J.A.A. A comparison of bathwater and oral delivery of 8-methoxypsoralen in PUVA therapy for plaque psoriasis. Clin Exp Dermatol 25 (2000) 111-114
8. Degitz K., Plewig G., and Röcken M. Rapid decline in photosensitivity after 8-methoxypsoralen bathwater delivery. Arch Dermatol 132 (1996) 1394-1395
9. Schempp C.M., Schöpf E., and Simon J.C. Phototesting in bath-PUVA: marked reduction of 8-methoxypsoralen (8-MOP) activity within one hour after an 8-MOP bath. Photodermatol Photoimmunol Photomed 12 (1996) 100-102
10. Neumannn N.J., Ruzicka T., and Lehmann P. Rapid decrease of phototoxicity after PUVA bath therapy with 8-methoxypsoralen. Arch Dermatol 132 (1996) 1394
11. Ortel B., Perl S., Kinaciyan T., Calzavara-Pinton P.G., and Hönigsmann H. Comparison of narrow-band (311 nm) UVB and broad-band UVA after oral or bath-water 8-methoxypsoralen in the treatment of psoriasis. J Am Acad Dermatol 29 (1993) 736-740
12. Tanew A., Kipfelsperger T., Seeber A., Radakovic-Fijan S., and Hönigsmann H. Correlation between 8-methoxypsoralen bath-water concentration and photosensitivity in bath-PUVA treatment. J Am Acad Dermatol 44 (2001) 638-642
13. Jansen C.T. Water temperature effect in bath-PUVA treatment. J Am Acad Dermatol 19 (1988) 142-143
14. Gruss C., Behrens S., von Kobyletzki G., Reuther T., Husebo L., Altmeyer P., et al. Effects of water temperature on photosensitization in bath-PUVA therapy with 8-methoxypsoralen. Photodermatol Photoimmunol Photomed 14 (1998) 145-147
15. Dolezal E., Seeber A., Hönigsmann H., and Tanew A. Correlation between bathing time and photosensitivity in 8-methoxypsoralen (8-MOP) bath PUVA. Photodermatol Photoimmunol Photomed 16 (2000) 183-185
16. Anigbogu A.N.C., Williams A.C., and Barry B.W. Permeation characteristics of 8-methoxypsoralen through human skin: relevance to clinical treatment. J Pharm Pharmacol 48 (1996) 357-366
17. Hönigsmann H., Jaschke E., Nitsche V., Brenner W., Rauschmeier W., and Wolff K. Serum levels of 8-methoxypsoralen in two different drug preparations: correlation with photosensitivity and UV-A dose requirements for photochemotherapy. J Invest Dermatol 79 (1982) 233-236
18. Hönigsmann H., Szeimies R.M., Knobler R., Fitzpatrick T.B., Pathak M.A., and Wolff K. Photochemotherapy and photodynamic therapy. In: Freedberg I.M., Eisen A.Z., Wolff K., Austen K.F., Goldsmith L.A., and Katz S.I. (Eds). Fitzpatrick's dermatology in general medicine (2003), McGraw-Hill, New York 2477-2493
19. Hannuksela A., Pukkala E., Hannuksela M., and Karvonen J. Cancer incidence among Finnish patients with psoriasis treated with trioxsalen bath PUVA. J Am Acad Dermatol 35 (1996) 685-689
20. Hannuksela-Svahn A., Pukkala E., Koulu E., Jansen C.T., and Karvonen J. Cancer incidence among Finnish psoriasis patients treated with 8-methoxypsoralen bath PUVA. J Am Acad Dermatol 40 (1999) 694-696